Effect of dofetilide on the pharmacokinetics of digoxin

Am J Cardiol. 2001 Jan 15;87(2):248-50, A9-10. doi: 10.1016/s0002-9149(00)01332-1.

Abstract

The effect of dofetilide on the steady-state pharmacokinetics of digoxin was evaluated in a randomized, double-blind study. Five days of dofetilide treatment did not significantly affect steady-state pharmacokinetic variables of digoxin compared with placebo; therefore, the use of dofetilide does not necessitate an adjustment in digoxin dose to maintain therapeutic digoxin levels.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents / blood
  • Anti-Arrhythmia Agents / pharmacokinetics
  • Anti-Arrhythmia Agents / pharmacology*
  • Digoxin / blood
  • Digoxin / pharmacokinetics*
  • Digoxin / pharmacology
  • Double-Blind Method
  • Drug Interactions
  • Humans
  • Male
  • Phenethylamines / blood
  • Phenethylamines / pharmacology*
  • Sulfonamides / blood
  • Sulfonamides / pharmacology*

Substances

  • Anti-Arrhythmia Agents
  • Phenethylamines
  • Sulfonamides
  • Digoxin
  • dofetilide